Clinical use of mean nocturnal baseline impedance and post-reflux swallow-induced peristaltic wave index for the diagnosis of gastro-esophageal reflux disease Pierfrancesco VisaggiLucia MarianiNicola de Bortoli Review Article Open access 29 June 2022 Pages: 525 - 534
Increasing incidence of eosinophilic esophagitis in Sweden: a nationwide population study John J. GarberPaul J. LochheadJonas F. Ludvigsson Original Article 02 June 2022 Pages: 535 - 541
Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study John J. GarberBjorn RoelstraeteJonas F. Ludvigsson Original Article Open access 28 June 2022 Pages: 542 - 553
Distal esophageal wall thickness correlates with dysphagia in adult patients with eosinophilic esophagitis Stephanie WongMarcus TippettNam Q. Nguyen Original Article 06 June 2022 Pages: 554 - 559
International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030 Yushi LinHong-liang WangJie Wu Original Article 11 June 2022 Pages: 560 - 568
A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan Yasuaki NakajimaHisateru TachimoriYuko Kitagawa Original Article 28 July 2022 Pages: 569 - 575
Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer Kazuchika OhnoMotomi NasuTakahiro Asakage Original Article 07 May 2022 Pages: 576 - 585
Handgrip strength predicts early postoperative dysphagia after thoracoscopic–laparoscopic esophagectomy in male patients with esophageal cancer Daisuke KuritaDaichi UtsunomiyaHiroyuki Daiko Original Article 05 June 2022 Pages: 586 - 595
Early postoperative weight loss is associated with poor prognosis in patients with esophageal cancer Kei YamamotoKoji TanakaYuichiro Doki Original Article 20 July 2022 Pages: 596 - 603
Urinary protein biomarker panel predicts esophageal squamous carcinoma from control cases and other tumors Linlin JiJianping WangGuangshun Wang Original Article 06 July 2022 Pages: 604 - 616
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma Masaaki ItoTakaki HiwasaHideaki Shimada Original Article 03 July 2022 Pages: 617 - 625
Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis Noriyuki NishiwakiKazuhiro NomaToshiyoshi Fujiwara Original Article 06 July 2022 Pages: 626 - 638
Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in Japan Keiichi JinguRei UmezawaNoriyuki Kadoya Original Article 16 May 2022 Pages: 639 - 644
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma Renma ItoYoshiaki NakamuraTakashi Kojima Original Article Open access 28 July 2022 Pages: 645 - 652
The benefit of concurrent chemotherapy with radiotherapy for esophageal cancer is limited in Asian patients aged 80 years or older: a SEER database analysis Keiichi JinguNoriyoshi TakahashiAyaka Harigai Original Article 02 July 2022 Pages: 653 - 659
Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy Sifen WangChao ZhangMian Xi Original Article 13 April 2022 Pages: 660 - 669
Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial V. NoronhaV. M. PatilK. Prabhash Original Article 26 May 2022 Pages: 670 - 682
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590 Takashi KojimaHiroki HaraKen Kato Original Article Open access 07 June 2022 Pages: 683 - 692
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma Jhe-Cyuan GuoChia-Chi LinChih-Hung Hsu Original Article 11 July 2022 Pages: 693 - 701
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303) Takashi KojimaKen KatoToshihiko Doi Original Article Open access 29 July 2022 Pages: 702 - 710
A phase II study of S-1 therapy for patients with advanced and recurrent esophageal cancer resistant or intolerable to fluorouracil, platinum, and taxane therapy (OGSG 1404) Motoo NomuraTakayuki KiiTaroh Satoh Original Article 20 June 2022 Pages: 711 - 716
Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma Shijia WangBaoyan JiZefen Xiao Original Article 27 June 2022 Pages: 717 - 725
Correction to: Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 and Part 2 Yuko KitagawaTakashi UnoMasahiro Yoshida Correction 27 June 2022 Pages: 726 - 726
